| Literature DB >> 35649084 |
Elaine Monteiro Matsuda1, Isabela Penteriche de Oliveira1, Laura Ballesteros Bao1, Fernanda Matsuda Manzoni1, Norberto Camilo Campos2, Beatriz Brajal Varejão1, Maristelly Pereira Leal2, Vania Barbosa Nascimento3, Luís Fernando de Macedo Brígido2.
Abstract
The world has been dealing with Aids for forty years, covid-19 accentuated societal inequalities and promoted a rupture in care and prevention, including for people living with HIV. We compiled official HIV indicators, analyzed the impact of covid-19 in Brazil, at São Paulo State (SP), and compared it to the municipality of Santo André (in the state of São Paulo), which adopted linkage/retention strategies to mitigate the impact of covid-19. From 2019 to 2020, suppression/adhesion rates remained stable. The number of new treatments decreased both in Brazil (-19.75%) and São Paulo (-16.44%), but not in Santo André, where 80% of new patients started treatment within 30 days from their first TCD4 test (70% in São Paulo and 64% in Brazil). However, PrEP dispensing increased during this period. The distribution of 2,820 HIV self-tests in Santo André lead to only one documented new HIV diagnosis linked to care. Synergistic strategies to swiftly diagnose and connect new cases, ensuring retention as well as rescuing missing patients deserve priority in the fight against HIV, especially in times of covid-19.Entities:
Mesh:
Year: 2022 PMID: 35649084 PMCID: PMC9126580 DOI: 10.11606/s1518-8787.2022056004314
Source DB: PubMed Journal: Rev Saude Publica ISSN: 0034-8910 Impact factor: 2.772
HIV care parameters obtained from the covid-19 HIV panel 2019–2021.
| Numbers of ART dispensation | PLWH linked | Numbers of CD4 count tests | Numbers of HIV viral load tests | PLWH that started ART | Numbers of HIV self-tested distribution | Number of PrEP dispensations | Number of PEP dispensations | ||
|---|---|---|---|---|---|---|---|---|---|
| Brazil | 2019 | 4,844,525 | 675,786 | 455,554 | 919,516 | 73,030 | 56,703 | 50,341 | 112,613 |
| 2020 | 4,143,652 | 705,261 | 306,009 | 732,287 | 58,933 | 172,606 | 71,147 | 96,419 | |
| 2021a | 3,900,442 | 738,979 | 361,648 | 864,430 | 61,652 | 93,972 | 86,834 | 102,940 | |
| ∆2019–2020 | -14.5 | 4.4 | -32.8 | -20.4 | -19.3 | 204 | 41.3 | -14.4 | |
| ∆2020–2021a | -5.9 | 4.8 | 18.2 | 18.0 | 4.6 | -45.6 | 22.0 | 6.8 | |
| São Paulo | 2019 | 1,040,794 | 163,188 | 101,954 | 232,568 | 13,505 | 36,772 | 22,320 | 41,029 |
| 2020 | 9,31,576 | 168,433 | 78,400 | 197,128 | 11,642 | 92,666 | 34,144 | 34,777 | |
| 2021a | 875,110 | 174,340 | 89,614 | 230,226 | 11,742 | 54,026 | 41,048 | 35,908 | |
| ∆2019–2020 | -10.5 | 3.2 | -23.1 | -15.2 | -13.8 | 152 | 53.0 | -15.2 | |
| ∆2020–2021a | -6.1 | 3.5 | 14.3 | 16.8 | 0.9 | -41.7 | 20.2 | 3.3 | |
| Santo André | 2019 | 17,724 | 2,432 | 1,249 | 3,746 | 183 | 6 | 386 | 733 |
| 2020 | 13,956 | 2,549 | 683 | 2,852 | 176 | 2,820 | 457 | 706 | |
| 2021a | 11,716 | 2,644 | 820 | 3,014 | 154 | 274 | 484 | 636 | |
| ∆2019–2020 | -21.3 | 4.8 | -45.3 | -23.9 | -3.8 | 46,900 | 18.4 | -3.7 | |
| ∆2020–2021a | -16.1 | 3.7 | 20.1 | 5.7 | -12.5 | -90.3 | 5.9 | -9.9 |
ART: antiretroviral; PLWH: persons living with HIV; PrEP: pre-exposure prophylaxis; PEP: postexposure prophylaxis.
a HIV indicators for all the country, São Paulo state and City of Santo André at pre-pandemic (2019) and two pos pandemic years 2020 e 2021, the latter projected from the first semester, and ∆ the variation 2019–2020 and 2020–2021 as percentage of change.
Figure 1Proportion of variation of covid-19 HIV panel data between 2019–2020 and 2020–2021a.
HIV clinical indicators (2019–2020) in Brazil, São Paulo state and city of Santo André.
| Late diagnosis (%) | ART within 30 days (%) | Linked | Started ART | On ART | Timely start of ART (%) | Viral suppression (%) | Sustained suppression (%) | Sufficient adhesion (%) | Insufficient adhesion (%) | Loss of follow-up (%) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brazil | 2019 | 26 | 58 | 753,316 | 68,527 | 633,699 | 35 | 88 | 74 | 73 | 18 | 9 |
| 2020 | 27 | 64 | 757,075 | 54,995 | 665,080 | 35 | 89 | 76 | 78 | 13 | 9 | |
| ∆2019–2020 | 1 | 6 | 0.50 | 4.95 | 0 | 1 | 2 | 5 | -5 | 0 | ||
| São Paulo | 2019 | 23 | 61 | 179,763 | 12,820 | 150,986 | 38 | 90 | 76 | 75 | 16 | 10 |
| 2020 | 23 | 70 | 179,859 | 10,713 | 158,608 | 37 | 91 | 78 | 79 | 13 | 8 | |
| ∆2019–2020 | 0 | 9 | 0.05 | -16.44 | 5.05 | -1 | 1 | 2 | 4 | -3 | -2 | |
| Santo André | 2019 | 27 | 82 | 2,714 | 181 | 2,381 | 43 | 92 | 78 | 80 | 14 | 6 |
| 2020 | 23 | 84 | 2,724 | 181 | 2,449 | 31 | 93 | 80 | 87 | 6 | 7 | |
| ∆2019–2020 | -4 | 2 | 0.37 | 2.86 | -12 | 1 | 2 | 7 | -8 | 1 |
Data for all the country, only the São Paulo state and only City of Santo André at pre-covid-19 pandemic (2019) and first covid-19 pandemic year (2020), with ∆, variation (percentage).
ART: antiretroviral; Late diagnosis: percentage of individuals with a first count of T CD4 cells record < 200 cells/mL; Treatment within 30 days: Percentage of individuals eligible for ART who started treatment within one month after performed the first count of T CD4 cells; Linked: number of individuals with at least one dispensation, one T CD4 cells or viral load collection; Started ART: number of individuals who started ART; On ART: number of persons living with HIV (PLWH) on ART (at least one medication dispensing, or withdraw, in the last 100 days); Timely start of ART: proportion of individuals starting ART with T CD4 cells > 500 cells/mL; Viral suppression (percentage of viral suppression): all individuals on ART (dispensed in the last 100 days of the year) who performed viral load, whose result was below 50 copies/mL; Sustained suppression: percentage of individuals on ART (withdraw in the last 100 days of the year, for at least two years and who performed at least 02 viral load tests with results below 50 copies/mL after at least 06 months from the beginning of the treatment; Sufficient adhesion: proportion of individuals with more than 80% ART adherence at the end of each year. Insufficient adhesion: proportion of individuals with at least one withdrawal of ARV, but with more than 80% adherence at the end of each year; Loss of follow-up: proportion of individuals without at least one withdrawal at the end of each year.
Figure 2Mortality rate due to covid-19 in Brazil, in São Paulo State, and the municipality of Santo André.